A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease

Margaret A. Fischl, Heather J. Ribaudo, Ann C. Collier, Alejo Erice, Marina Giuliano, Marjorie Dehlinger, Joseph J. Eron, Michael S. Saag, Scott M. Hammer, Stefano Vella, Gene D. Morse, Judith E. Feinberg

Research output: Contribution to journalArticle

69 Scopus citations

Abstract

To compare long-term virologic benefits of antiretroviral regimens in persons with advanced human immunodeficiency virus (HIV) disease, a randomized, open-label study was conducted of 517 subjects with no or limited previous experience with antiretroviral therapy. Subjects received lamivudine plus zidovudine and indinavir (indinavir group), efavirenz plus indinavir (efavirenz + indinavir group), or nelfinavir plus indinavir (nelfinavir + indinavir group) and were monitored for 2.1 years. Virologic failure was lower in the efavirenz + indinavir group (P = .04) and higher in the nelfinavir + indinavir group (P = .006), compared with that in the indinavir group. No difference in grade 3 or 4 adverse event rates in the efavirenz + indinavir group (P = .97) and a trend toward an increased rate in the nelfinavir + indinavir group (P = .07), compared with the indinavir group, were noted. A 4-drug regimen containing efavirenz plus indinavir resulted in a superior virologic response, whereas one containing nelfinavir plus indinavir resulted in an inferior response and a greater likelihood of toxicity.

Original languageEnglish (US)
Pages (from-to)625-634
Number of pages10
JournalJournal of Infectious Diseases
Volume188
Issue number5
DOIs
StatePublished - Sep 1 2003

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease'. Together they form a unique fingerprint.

  • Cite this

    Fischl, M. A., Ribaudo, H. J., Collier, A. C., Erice, A., Giuliano, M., Dehlinger, M., Eron, J. J., Saag, M. S., Hammer, S. M., Vella, S., Morse, G. D., & Feinberg, J. E. (2003). A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease. Journal of Infectious Diseases, 188(5), 625-634. https://doi.org/10.1086/377311